Support for Adolescents Living With HIV in South Africa
InTSHA VIP
Interactive Transition Support for Adolescents Living With HIV Comparing Virtual and In-person Delivery Through a Stepped-wedge Cluster Randomized Clinical Trial in South Africa
3 other identifiers
interventional
570
1 country
1
Brief Summary
This is a cluster randomized controlled trial determining the effectiveness of in-person or mHealth-based adolescent-friendly transition interventions compared to standard care on retention in care and viral suppression among adolescents living with HIV who have low transition readiness. Participants are adolescents living with HIV ages 15 to 19 years old in KwaZulu-Natal, South Africa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Start
First participant enrolled
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
March 9, 2026
March 1, 2026
3.9 years
September 6, 2023
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Retained in Care
Clinic patients are considered to be retained in care if 80% of ART pharmacy refills are filled on time (\< 7days from scheduled date) and 80% of scheduled clinic appointments are attended.
After the 9 month intervention (Month 9 or Month 18)
Change in Number of Participants with Viral Suppression
HIV-1 viral load is measured in viral copies per milliliter (mL) of blood and viral suppression is defined as \<200 copies/ml.
Baseline, After the 9 month intervention (Month 9 or Month 18)
Secondary Outcomes (10)
Acceptability of Intervention Measure (AIM) Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
Intervention Appropriateness Measure (IAM) Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
Feasibility of Intervention Measure (FIM) Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
HIV Adolescent Readiness for Transition Scale (HARTS) Score
Baseline, Month 9, Month 18, Month 24
Participation Rate
Baseline, After the 9 month intervention (Month 9 or Month 18)
- +5 more secondary outcomes
Other Outcomes (5)
Child and Adolescent Social Support Scale (CASSS) Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
Rosenberg's Self-Esteem Scale Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
Patient Health Questionnaire (PHQ-9) Score
Baseline, After the 9 month intervention (Month 9 or Month 18)
- +2 more other outcomes
Study Arms (5)
In-person adolescent-friendly service (iPAS) intervention:
EXPERIMENTALAdolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the in-person supported adolescent friendly services will attend their clinic after school hours on a designated day or on weekends dedicated for adolescent care monthly for 9 months.
mHealth (InTSHA) intervention
EXPERIMENTALAdolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the mHealth intervention will receive the InTSHA intervention based in the Got Transition elements and the SMART model for 9 months.
Standard of Care/Delayed Intervention
ACTIVE COMPARATORAdolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to deliver the standard of care before transitioning to adult care in their standard local adult clinic. Participants will be invited to receive the intervention the clinic is randomized to deliver when the 9 month period of administering the standard of care is complete.
Healthcare Providers
NO INTERVENTIONHealthcare providers working at one of study clinics, administering the study intervention selected for that clinic.
Observational cohort
NO INTERVENTIONAdolescents at study clinics who score high on transition readiness during screening will not be invited to enroll in the study but will be asked for their consent to have their clinic records reviewed for medical records, retention data and transition readiness data. They will also complete a questionnaire at Months 9, 18, and 24.
Interventions
Monthly visits take place in a group setting with sessions led by peer educators. Clinical staff and peer educators are trained in care of adolescents using the Right to Care training materials. During their clinic visit, adolescents are evaluated individually by a healthcare provider and receive their supply of ART. In addition, adolescents participate in scheduled group team-building activities including dancing, sports, music and receive group counseling facilitated by peer educators. Nine group counseling sessions will discuss the topics of: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. The half-day sessions will end with the provision of a meal. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.
The InTSHA intervention is based on Got Transition elements (two-way messaging between adolescents and healthcare providers) and the SMART model. The SMART model focuses on modifiable factors of transition preparation through content delivery, facilitated discussions, online meet ups and consultation with the healthcare team. The intervention consists of 9 modules delivered monthly by group chat. The topics of the modules are: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. Outside of scheduled group chat sessions, adolescents have access to the chat group to check in with members, review content of the sessions, or to comment or ask additional questions. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.
Adolescents in standard of care are seen every three months by clinicians and collect medication monthly at an on-site pharmacy during regular weekdays. Individual counseling delivered by counselors or social workers is available when necessary. Staff at all clinics receive training in adolescent-friendly services (AFS) through the Right to Care training materials.
Eligibility Criteria
You may qualify if:
- Aged 15 to 19 years at enrollment
- Living with perinatally-acquired HIV
- Receiving ART for at least 6 months
- Aware of their HIV status
- Scoring low to intermediate on transition readiness assessment (intervention cohort only)
- Profession as a healthcare provider
- Working at one of the designated clinics
- Involvement with adolescents before, during or after transition to adult care
You may not qualify if:
- Inability to read and/or speak English or Zulu
- Severe mental or physical illness preventing participation in informed consent activities
- Anticipated move out of clinic area in the next 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- University of KwaZulucollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
King Edward VIII Hospital
KwaKhangela, South Africa
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian C Zanoni, MD, MPH
Emory University
- PRINCIPAL INVESTIGATOR
Mohendran Archary, MBchB
King Edward VIII Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 13, 2023
Study Start
February 2, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be made available for sharing following publication of results from this study.
- Access Criteria
- Data will be made available for sharing through the Emory Dataverse. The Dataverse website can be accessed by any researcher for secondary analyses.
De-identified, individual participant data will be made available for sharing, including demographic information, clinic information, and study and survey data.